Depomedrol (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 70 | 広範脊柱管狭窄症 | 3 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02459392 (ClinicalTrials.gov) | December 2020 | 26/5/2015 | EuroPainClinics® Study II (Prospective Trial) | EuroPainClinics® Study II (Prospective Randomized Double Blinded Trial) | Lumbar Spinal Stenosis | Other: Epiduroscopy;Drug: Hyaluronic Acid;Drug: DepoMedrol | Europainclinics z.ú. | NULL | Recruiting | 18 Years | N/A | All | 300 | N/A | Czechia;Czech Republic |
| 2 | NCT02932020 (ClinicalTrials.gov) | October 2016 | 4/10/2016 | AlloGen-LI Treatment of Spinal Stenosis | Pilot Study Investigating the Utility of Epidural AlloGen-LI Injection for Treatment of Spinal Stenosis Symptoms | Low Back Pain | Drug: AlloGen-LI;Drug: depomedrol;Device: MRI;Drug: 0.5% marcaine | University of Southern California | Vivex Biomedical, Inc. | Withdrawn | 18 Years | N/A | All | 0 | N/A | United States |
| 3 | NCT00370799 (ClinicalTrials.gov) | January 2007 | 30/8/2006 | Effectiveness of Caudal Epidural Injections in Treatment of Chronic Low Back and Lower Extremity Pain | A Randomized, Prospective, Double-Blind Controlled Evaluation of the Effectiveness of Caudal Epidural Injections in Lumbar Disc Herniations, Spinal Stenosis, Discogenic Pain, and Post-Lumbar Laminectomy Syndrome | Low Back Pain | Drug: Caudal epidural injection;Drug: Caudal Epidural Injection with generic Celestone;Drug: Caudal Epidural Injection with Celestone;Drug: Caudal Epidural Injection with DepoMedrol | Pain Management Center of Paducah | NULL | Completed | 18 Years | N/A | Both | 240 | Phase 0 | United States |